膀胱全切除输尿管皮肤造瘘治疗高龄T<sub>3</sub>期膀胱肿瘤的体会(附47例报告)

张心如; 乔勇; 谷宝军; 金三宝; 陈嵘; 金重睿; 司捷旻

膀胱全切除输尿管皮肤造瘘治疗高龄T₃期膀胱肿瘤的体会(附47例报告)

- 上海交通大学附属第六人民医院泌尿外科(上海, 200233)

详细信息

通讯作者: 张心如,E-mail:zhangxinru@gmail.com

中图分类号: R737.14

收稿日期: 2012-06-26

Experience on treating the elder patients with cT₃ bladder tumor by cystectomy and ureterocutaneostomy(Report of 47 cases)

- Department of Urology, Shanghai Jiaotong University Affiliated Shanghai Sixth People's Hospital, Shanghai, 200233, China

More Information

Corresponding author: ZHANG Xinru, E-mail: zhangxinru@gmail.com

Received Date: 26 June 2012

摘要

摘要: 目的：总结高龄T₃期膀胱肿瘤行全膀胱切除并输尿管皮肤造瘘的经验。方法：2004~2011年，47例超过75岁T₃期膀胱肿瘤患者接受全膀胱切除并输尿管皮肤造瘘，9例为初发，38例为复发肿瘤，既往平均手术次数（2.7±1.7）次。25例（53.2%）合并有其他器官的慢性疾病。所有患者于术中同时行双侧盆腔淋巴清扫，1例因尿道腔内肿瘤生长行尿道全切除并阴道前壁部分切除。术后输尿管内留置F₇单J支架管并定期更换。以QLQ-C30（v3.0）中文版量表评价患者术前，术后6个月，12个月的生活质量。结果：47例均顺利完成手术，无术中或围手术期死亡病例。手术平均时间（266±33） min，围手术期平均输血（728±309）ml。术后病理分级T_2b 2例，T_3a 26例，T_3b 15例，T_4a 4例，N₂ 14例，N₃ 1例。随访11~67个月，平均（32.4±15.1）个月。23例（48.9%）术后3~36个月出现肿瘤复发及转移。24例（40.4%）随访中死亡，17例死于肿瘤转移，7例死于非肿瘤相关原因。23例生存至今，19例（40.4%）无瘤生存15~67个月，平均（41.5±16.2）个月，4例（8.5%）带瘤生存19~30个月。17例（36.2%）出现并发症：7例单侧肾功能下降，1例双侧肾功能减退。11例经历至少1次肾盂肾炎（2例合并单侧肾功能减退）。32例完成术后6个月QLQ-C30测定，22例完成术后12个月测定，经统计检验，术后6个月患者情绪功能改变以及术后6个月，12个月患者的主观健康状况及生活质量均与术前存在显著统计学差异。结论：高龄T₃期膀胱肿瘤患者可耐受全膀胱切除，应于术中尽量缩短手术时间，缩小手术区域，以提高患者手术耐受能力。对于高龄患者，输尿管皮肤造瘘并于输尿管内长期留置输尿管支架是全膀胱切除后简便，安全，并发症少且处理简单的尿流改道方式。全膀胱切除术对提高高龄T₃膀胱肿瘤患者术后生活质量和主观健康状况有积极意义。
- 膀胱肿瘤 /
- 肌层浸润性 /
- 高龄 /
- 全膀胱切除 /
- 输尿管皮肤造瘘 /
- 生活质量 /
- QLQ-C30(v3.0)中文版
Abstract: Objective: To study our experience on treating the elder patients with cT₃ bladder tumor by cystectomy and ureterocutaneostomy.Method: From 2004.1 to 2011.12,47 patients over 75 years old with cT₃ bladder tumor underwent cystectomy and ureterocutaneostomy in our hospital. 9 cases were primary tumor and the rest were recurrence tumor. An average(2.7±1.7)pervious procedures were underwent before surgery. 25 cases(53.2%)had no urinary system related comorbidities. All the patients accepted bilateral pelvic lymphadenectomy at the same time when cystectomy was performed. Urethra was resected in 1 case due to cancer infiltration. F7 ureteral single J stents were indwelled in each ureter and replaced regularly every two months. EORTC QLQ-C30(v3.0)Chinese version was used in preoperation,6^th and 12^th months postoperative to assess the quality of life of patients.Result: No death was reported during peroperative period. Mean operation time was(266±33)minutes and mean blood transfusion during preoperative period was(728±309)ml. Postoperative pathologic examination staged T_2b in 2 cases,T_3a in 26 cases,T_3b in 15 cases,T_4a in 4 cases,while N₂ in 14 cases,and N₃ in 1 case. Within the average(32.4±15.1)months follow up(11-67 months),23 cases(48.9%)were detected tumor recurrence or metastasis within 3 to 36 months postoperatively. Among 24 cases who died(40.4%)during the follow up,17 cases died with tumor metastasis and 7 cases died with no tumor related reasons.Among 23 survival patients,19 patients(40.4%)accomplished no tumor survival from 15 to 67 month,mean(41.5±16.2)months. 4 patients(8.5%)survived with tumor from 19 to 30 months.17 patients(36.2%)were reported complications occurred. Unilateral renal function deterioration was detected in 7 patients and bilateral renal function deterioration was detected in 1 patient. 11 patients experienced at least once pyelonephritis during the follow up(2 of them combined with unilateral renal function deterioration). 32 patients finished QLQ-C30(v3.0)assessment at 6^th month postoperatively and 22 patients finished the assessment at 12^th month postoperatively. The statistics difference was found in the emotion function,subjective healthy status and quality of life between preoperation and 6^th month postoperatively,as well as the subjective healthy status and quality of life between preoperation and 12^th month postoperatively.Conclusion: Cystectomy could be performed in elder cT₃ bladder tumor patients. Reducing the operative time,minimizing the surgical area should be considered to improve the tolerance. Ureterocutaneostomy and indwelling ureteral stent is a safe and convenience urinary diversion way for the elder patients. Its complications are limited and can be treated easily. To the elder cT₃ bladder tumor patients,cystectomy and ureterocutaneostomy could improve their postoperative quality of life and subjective health status.
- bladder tumor /
- muscle invasive /
- elder /
- cystectomy /
- ureterocutaneostomy /
- quality of life /
- QLQ-C30(v3.0)Chinese version

HTML全文

参考文献(27)

[1]	SONPAVDE G,KHAN M M,LERNER S P,et al. Disease-freesurvivalat 2 or 3 years correlates with 5-year overallsurvivalof patients undergoing radical cystectomy for muscle invasive bladder cancer[J].J Urol,2011,185:456-461.
[2]	NAGELE U,ANASTASIADIS A G,STENZL A,et al. Radical cystectomy with orthotopic neobladder for invasive bladder cancer:a critical analysis of long-term oncological,functional,and quality of life results[J]. World J Urol,2011,5.[Epub ahead of print]
[3]	HAUTMANN R E,de PETRICONI R C,PFEIFFER C,et al. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy:long-term results in 1100 patients[J]. Eur Urol,2012,61:1039-1047.
[4]	MAY M,BASTIAN P J,BROOKMAN-MAY S,et al. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder[J]. J Urol,2012,187:1210-1204.
[5]	MITRA A P,QUINN D I,DORFF T B,et al. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy[J]. BJU Int,2012,109:846-854.
[6]	STEIN J P,QUEK M L,SKINNER D G. Lymphadenectomyforinvasivebladder cancer:I. historical perspective and contemporary rationale[J]. BJU Int,2006,97:227-231.
[7]	FROEHNER M,BRAUSI M A,HERR H W,et al. Complications following radical cystectomy for bladder cancer in the elderly[J]. Eur Urol,2009,56:443-454.
[8]	NOVOTNY V, ZASTROW S, KOCH R, et al. Radical cystectomy in patients over 70 years of age:impact of comorbidity on perioperative morbidity and mortality[J]. World J Urol,2011,2.[Epub ahead of print]
[9]	PYCHA A,COMPLOJ E. Thedilemmaofcystectomyinold-oldandoldest-oldpatients[J]. Expert Rev Anticancer Ther,2011,11:1863-1870.
[10]	SOULIÉ M,STRAUB M,GAMÉ X,et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer[J]. J Urol, 2002, 167:1325-1328.
[11]	SHARIAT S F,MILOWSKY M,DROLLER M J. Bladder cancer in the elderly[J]. Urol Oncol,2009,27:653-667.
[12]	SEHL M,SAWHNEY R,NAEIM A. Physiologic aspects of aging:impact on cancer management and decision making, part II[J]. Cancer J, 2005, 11:461-473.
[13]	CHAMIE K,HU B,DEVERE WHITE R W,et al. Cystectomy in the elderly:does the survival benefit in younger patients translate to the octogenarians[J]? BJU Int,2008,102:284-290.
[14]	CLARK P E,STEIN J P,GROSHEN S G,et al. Radical cystectomy in the elderly:comparison of survival between younger and older patients[J]. Cancer,2005,103:546-552.
[15]	李宁忱. 膀胱癌诊断治疗指南[M]. 见:那彦群,叶章群,孙光主编. 中国泌尿外科疾病诊断治疗指南(2011版). 北京:人民卫生出版社,2011:35-37.
[16]	BRAUSI M A. The motion:radical cystectomy in the elderly is becoming a standard treatment for bladder cancer[J]. Eur Urol,2007,51:1435-1436.
[17]	KAOUK J H,GOEL R K,WHITE M A,et al. Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection:initial experience and 2-year follow-up[J]. Urology,2010,76:857-861.
[18]	CATHELINEAU X,ARROYO C,ROZET F,et al. Laparoscopic assisted radical cystectomy:themontsourisexperienceafter84cases[J]. Eur Urol,2005,47:780-784.
[19]	HUANG J, LIN T, LIU H, et al. Laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer:oncologic results of 171 cases with a median 3-year follow-up[J]. Eur Urol,2010,58:442-449.
[20]	MADERSBACHER S,BAUER W,WILLINGER M,et al. Radical cystectomy for bladder cancer in the 70+ population:a nation wide registry analysis of 845 patients[J]. Urol Int,2010,85:287-290.
[21]	LUGHEZZANI G,SUN M,SHARIAT S F,et al. A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer[J]. Cancer,2011,117:103-109.
[22]	MESSING E. Urothelial tumors of the bladder[M]. In:WEIN A J. Campbell-Walsh Urology. 9th ed. Pennsylrania, 2008:2409-2416.
[23]	LANCE R S, DINNEY C P, SWANSON D, et al. Radical cystectomy for invasive bladder cancer in the octogeranrians[J]. Oncol Rep, 2001, 8:723-726.
[24]	LIGUORI G, TROMBETTA C, POMARA G, et al. Major invasive surgery for urological cancer in octogenarians with comorbid medical conditions[J]. Eur Urol, 2007, 51:1600-1604.
[25]	LODDE M, PALERMO S, COMPLOJ E, et al. Four years experience in bladder preserving management for muscle invasive bladder cancer[J]. Eur Urol, 2005, 47:773-778.
[26]	AARONSON N K, AHMEDZAI S, BERGMAN B, et al. The european organization for research and treatment of cancer QLQ-C30:a quality of life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst, 1993, 85:365-376.
[27]	万崇华, 陈明清, 张灿珍, 等. 癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J]. 实用肿瘤杂志, 2005, 20(4):353-355.